Despite delay, KalVista wins FDA approval after Makary's short-lived attempt to intervene
The FDA has approved KalVista Pharmaceuticals’ drug for a rare swelling disease, the company announced on Monday, in a key win …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
